Cite
HARVARD Citation
Banchs, H. et al. (2006). 170 OUTCOMES OF HEART TRANSPLANT RECIPIENTS USING BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY: THE PUERTO RICAN EXPERIENCE.. Journal of investigative medicine. p. S286. [Online].